---
title: "Berkshire Hathaway, Cisco And A Health Care Stock: CNBC’s ‘Final Trades’"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305825682.md"
description: "CNBC's 'Final Trades' highlights Berkshire Hathaway, Cisco, and Eli Lilly. UBS raised its price target for Berkshire to $628, noting portfolio changes under CEO Greg Abel. Cisco reported strong Q1 results and raised FY27 revenue and earnings guidance, boasting a 5% free cash flow yield. Eli Lilly agreed to acquire Calytrix Bio for up to $1.5 billion. Despite positive news, shares of all three companies saw slight declines in recent trading sessions."
datetime: "2026-11-17T12:48:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305825682.md)
  - [en](https://longbridge.com/en/news/305825682.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305825682.md)
generator: "portal-rs"
---

# Berkshire Hathaway, Cisco And A Health Care Stock: CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” **Jim Lebenthal**, partner and chief market strategist at Cerity Partners, picked **Berkshire Hathaway Inc.** (NYSE:BRK).

On Oct. 22, UBS analyst Brian Meredith maintained a Buy rating on Berkshire Hathaway and raised the price target from $604 to $628.

The company, once led by **Warren Buffett**, made several changes to its portfolio under new CEO **Greg Abel**. For example, Berkshire Hathaway recently unveiled a new position in **Bending Spoons** (NASDAQ:BSP), which owns AOL, Eventbrite, NetScape, Streamyard, Vimeo and Airtable.

## Cisco Boasts a 5% Free Cash Flow Yield

**Jenny Van Leeuwen Harrington**, chief executive officer of Gilman Hill Asset Management, LLC, said **Cisco Systems, Inc.** (NASDAQ:CSCO) has a 5% free cash flow yield.

On the earnings front, Cisco reported better-than-expected first-quarter financial results on Nov. 12 and raised its FY27 guidance.

The company boosted its fiscal year 2027 revenue guidance from a range of $72.2 billion to $73.4 billion to a new range of $74.8 billion to $75.8 billion, versus estimates of $73.02 billion. The company also raised its full-year adjusted earnings outlook from a range of $5.05 to $5.11 per share to a new range of $5.47 to $5.53 per share, versus estimates of $5.11 per share.

*Don’t forget to check out our premarket coverage here* 

**Joseph M. Terranova**, senior managing director for Virtus Investment Partners, said **Eli Lilly and Company** (NYSE:LLY) continues to move higher.

Eli Lilly on Monday agreed to acquire Calytrix Bio Inc. for up to $1.5 billion in cash. Under the deal terms, Calytrix shareholders stand to receive an upfront cash payment plus additional payments upon meeting clinical and regulatory milestones.

## **Price Action**

-   Berkshire Hathaway shares slipped 0.02% to close at $592.85 on Monday.
-   Cisco shares declined 1.2% to close at $94.52.
-   Eli Lilly shares fell 0.8% to settle at $1,431.67 during the session.

 **See More: Top Value Stocks** 

*Photo via Shutterstock*

### Related Stocks

- [BRK.A.US](https://longbridge.com/en/quote/BRK.A.US.md)
- [BRK.B.US](https://longbridge.com/en/quote/BRK.B.US.md)
- [CSCO.US](https://longbridge.com/en/quote/CSCO.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [BRKC.US](https://longbridge.com/en/quote/BRKC.US.md)
- [BRKD.US](https://longbridge.com/en/quote/BRKD.US.md)
- [BRKU.US](https://longbridge.com/en/quote/BRKU.US.md)
- [BRKW.US](https://longbridge.com/en/quote/BRKW.US.md)
- [CSCL.US](https://longbridge.com/en/quote/CSCL.US.md)
- [CSCS.US](https://longbridge.com/en/quote/CSCS.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [07777.HK](https://longbridge.com/en/quote/07777.HK.md)

## Related News & Research

- [Stipple Bio Enters Multi-Target Oncology Collaboration With Eli Lilly](https://longbridge.com/en/news/305722464.md)
- [What Eli Lilly Buyers Were Betting On](https://longbridge.com/en/news/306030556.md)
- [LLY Stock: Is It Still a Buy at Record Highs?](https://longbridge.com/en/news/306126463.md)
- [Cisco Non-GAAP EPS of $1.40 beats by $0.07, revenue of $18.52B beats by $390M](https://longbridge.com/en/news/305370518.md)
- [Lilly signs cancer research deal with Stipple Bio worth up to $5.9 billion](https://longbridge.com/en/news/305722471.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**